Genomic Health, Inc., founded in August of 2000 and located in Redwood City, California, is building an oncology-based health care services company for physicians and patients to provide individualized genomic analysis of tumor biopsies. Genomic Health has pioneered the use of high-throughput genomic analysis of fixed paraffin-embedded tissues to obtain and clinically validate genomic information in large-scale clinical trials. Genomic Health is using this extensive clinical experience to develop validated genomic services to provide individualized information on the likelihood of disease recurrence and response to therapy. Genomic Health’s goal is to improve the quality of treatment decisions for patients with cancer.